evans blue has been researched along with suramin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Baker, DL; Howard, AL; North, EJ; Parrill, AL; Pham, TC; Wanjala, IW | 1 |
| Arora, MP; Crowle, AJ | 1 |
| De Clercq, E; Desmyter, J; Pauwels, R; Schols, D | 1 |
| Franz, M; Giesbrecht, P; Wecke, J | 1 |
| Balzarini, J; Broder, S; De Clercq, E; Mitsuya, H | 2 |
| Khaled, Z; Stein, CA; Truneh, A; Vlassov, V; Yakubov, L; Zhang, LM | 1 |
| Bültmann, R; Starke, K | 1 |
| Chang, HC; Flanagan, DR | 1 |
| Eltze, M; Ullrich, B | 1 |
| Hirmo, S; Ljungh, A; Pascu, C; Wadström, T | 1 |
| Chen, SA; Jan, CR; Li, HF; Wu, SN | 1 |
| Bültmann, R; Starke, K; Trendelenburg, M; Tuluc, F; Wittenburg, H | 1 |
| Kwan, CY; Shen, JZ; Zheng, XF | 1 |
| Calil-Elias, S; El-Kik, CZ; Fernandes, FF; Fonseca, TF; Gaban, GA; Martinez, AM; Melo, PA; Oliveira, SD; Silva, CL; Tomaz, MA | 1 |
1 review(s) available for evans blue and suramin
| Article | Year |
|---|---|
Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adsorption; Antibodies, Viral; Antigens, Viral; Aurintricarboxylic Acid; Deltaretrovirus; Deoxycytidine; Foscarnet; Genes, Viral; Glycoproteins; Humans; Interferons; Male; Phosphonoacetic Acid; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Viral; Suramin; Thymidine; Transcription, Genetic; Viral Proteins; Virus Replication; Zalcitabine; Zidovudine | 1986 |
17 other study(ies) available for evans blue and suramin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.
Topics: Databases, Factual; Enzyme Inhibitors; Humans; Isoenzymes; Models, Molecular; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Quantitative Structure-Activity Relationship; Stereoisomerism; Sulfonic Acids | 2010 |
Adjuvanticity of Evans blue dye: preliminary characterization of its mechanisms and mode of application in mice.
Topics: Adjuvants, Immunologic; Animals; Antigens; Antigens, Bacterial; Azo Compounds; Conalbumin; Dose-Response Relationship, Immunologic; Evans Blue; Female; Hypersensitivity, Delayed; Immunization, Passive; Mice; Suramin; Trypan Blue | 1978 |
Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Topics: Antibodies, Monoclonal; Antiviral Agents; Aurintricarboxylic Acid; CD4-Positive T-Lymphocytes; Cell Line; Cell Separation; Dextran Sulfate; Dextrans; Dose-Response Relationship, Drug; Evans Blue; Flow Cytometry; Heparin; HIV Envelope Protein gp120; HIV-1; Humans; Pentosan Sulfuric Polyester; Suramin | 1990 |
Inhibition of the bacteriolytic effect of beta-lactam-antibiotics on Staphylococcus aureus by the polyanionic drugs suramin and Evans Blue.
Topics: Anti-Bacterial Agents; Azo Compounds; beta-Lactams; Cell Wall; Evans Blue; Microbial Sensitivity Tests; Microscopy, Electron; Staphylococcus aureus; Suramin | 1990 |
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
Topics: Animals; Antiviral Agents; Cell Transformation, Viral; Cytopathogenic Effect, Viral; Deltaretrovirus; Evans Blue; Mice; Mice, Inbred C3H; Moloney murine leukemia virus; Moloney murine sarcoma virus; Reverse Transcriptase Inhibitors; Ribavirin; Suramin; Virus Replication | 1986 |
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
Topics: Animals; Aurintricarboxylic Acid; Azo Compounds; Benzhydryl Compounds; Cell Division; Cyclohexanecarboxylic Acids; Cytopathogenic Effect, Viral; Deltaretrovirus; Evans Blue; Injections, Intraperitoneal; Leukemia L1210; Leukemia, Erythroblastic, Acute; Mammary Neoplasms, Experimental; Mice; Suramin; Viral Proteins | 1986 |
Oligodeoxynucleotides interact with recombinant CD4 at multiple sites.
Topics: Alkylating Agents; Aurintricarboxylic Acid; Binding Sites; Binding, Competitive; CD4 Antigens; Electrophoresis, Polyacrylamide Gel; Evans Blue; Oligodeoxyribonucleotides; Pentosan Sulfuric Polyester; Phosphates; Phosphorus Radioisotopes; Recombinant Proteins; Solutions; Suramin; Trypan Blue | 1993 |
Evans blue blocks P2X-purinoceptors in rat vas deferens.
Topics: Adenosine Triphosphate; Animals; Evans Blue; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Norepinephrine; Potassium; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Suramin; Vas Deferens | 1993 |
Liposomal entrapment of suramin(II): interaction of suramin with phospholipids of various chain lengths.
Topics: Azo Compounds; Calorimetry, Differential Scanning; Coloring Agents; Evans Blue; Liposomes; Membranes, Artificial; Phospholipids; Suramin; Temperature; Trypan Blue | 1995 |
Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney.
Topics: Adenosine Triphosphate; Animals; Dose-Response Relationship, Drug; Endothelium, Vascular; Evans Blue; Kidney; Male; Muscle, Smooth, Vascular; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Suramin; Trypanocidal Agents; Vascular Resistance; Vasoconstriction; Vasodilation | 1996 |
A particle agglutination assay for rapid identification of heparin binding to coagulase-negative staphylococci.
Topics: Agglutination Tests; Anti-Bacterial Agents; Anticoagulants; Carrageenan; Coagulase; Coloring Agents; Culture Media; Dalteparin; Endopeptidases; Evans Blue; Excipients; Heparin; Hot Temperature; Humans; Luminescent Measurements; Microspheres; Periodic Acid; Polysaccharides; Staphylococcus; Suramin; Time Factors; Trypan Blue; Tunicamycin | 1996 |
Stimulation of large-conductance Ca2+-activated K+ channels by Evans blue in cultured endothelial cells of human umbilical veins.
Topics: Adenosine Diphosphate; Capillary Permeability; Cells, Cultured; Endothelium, Vascular; Evans Blue; Humans; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Calcium-Activated; Suramin; Umbilical Veins | 1999 |
Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Anthraquinones; Evans Blue; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Naphthalenesulfonates; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P2X; Sensitivity and Specificity; Sulfonic Acids; Suramin; Triazines; Trypan Blue; Vas Deferens | 1999 |
Evidence for P(2)-purinoceptors contribution in H(2)O(2)-induced contraction of rat aorta in the absence of endothelium.
Topics: Adenosine Triphosphate; Alkaloids; Analysis of Variance; Animals; Aorta; Apyrase; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Catalase; Dantrolene; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Evans Blue; Hydrogen Peroxide; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nickel; Nifedipine; Procaine; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Signal Transduction; Superoxide Dismutase; Suramin; Triazines; Vasoconstrictor Agents | 2000 |
Neutralization of Apis mellifera bee venom activities by suramin.
Topics: Animals; Antivenins; Bee Venoms; Capillary Permeability; Cells, Cultured; Creatine Kinase; Edema; Endothelium, Vascular; Erythrocytes; Evans Blue; Hematocrit; Injections, Intramuscular; Longevity; Male; Mice; Muscle Contraction; Muscle Fibers, Skeletal; Phospholipases A2; Rats; Sarcolemma; Skin; Suramin | 2013 |